S

Synonym

Builds and leases scalable biomanufacturing facilities

Website

Overview

Synonym.bio builds and manages biomanufacturing infrastructure to scale microbial fermentation. It constructs production facilities and provides dedicated, scalable fermentation capacity to synthetic biology companies with minimal upfront capital. The company also offers asset management for investors, curating opportunities in biomanufacturing infrastructure and handling risk to maximize returns. By combining facility development, long-term leases, and investment management, Synonym.bio helps synbio startups reach the market faster while giving investors access to a growing asset class.

Work here?Claim your company

About Synonym

Simplify's Rating
Why Synonym is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Venture CapitalIndustrial & ManufacturingFinancial ServicesBiotechnology

Company Size

1-10

Company Stage

Series A

Total Funding

$26.6M

Headquarters

New York City, New York

Founded

2021

Get referred to Synonym

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • Oct 2025 Series A raised $20 million, validating financing-plus-development demand.
  • Aug 2024 DoD awarded $1.89 million for distributed bioindustrial manufacturing capabilities.
  • Oct 2025 Brenntag partnership expands bioproduct commercialization access across industrial customers.

What critics are saying

  • Liberation Labs' 600,000-liter Richmond plant in 2026 crushes Synonym on scale.
  • Synonym's $26.6 million funding cannot finance industrial rollout against capital-heavy incumbents.
  • If iPROOF slips beyond 2026, investors lose confidence in Synonym's first commercial proof.

What makes Synonym unique

  • Oct 2026 rebrand to Roebling bundled software, engineering, and facility development.
  • Capacitor and Match connect customers to fermentation capacity faster than brokers do.
  • Primient Decatur iPROOF gives Synonym a real-world operating site, not pure software.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$26.6M

Above

Industry Average

Funded Over

3 Rounds

Notable Investors:
Andreessen Horowitz
Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Above Average

Industry standards

$15M
$8.2M
$15M
$18.4M
$30M

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Company Equity
  • Unlimited Paid Time Off
  • 401(k) Retirement Plan

Company News

AlleyWatch
Nov 5th, 2025
The AlleyWatch Startup Daily Funding Report: 11/5/2025

The alleywatch startup daily funding report: 11/5/2025. The latest venture capital, seed, pre-seed, and angel deals for NYC startups for 11/5/2025 featuring funding details for Teleskope, AUI, and much more. This page will be updated throughout the day to reflect any new fundings. Teleskope - $25M Series A. Teleskope, a data protection and security platform, has raised $25M in Series A funding led by M13. Founded by Elizabeth Nammour and Julie Trias in 2022, Teleskope has now raised a total of $32.2M in reported equity funding. AUI - $20M venture. AUI, the company building neuro-symbolic foundation models for task-oriented conversational AI, has raised $20M in Venture funding from investors that include New Era Capital Partners and eGateway Capital. Founded by Ohad Elhelo and Ori Cohen in 2017, AUI has now raised a total of $63.1M in reported equity funding. Synonym - $18.4M. Synonym, a platform for accelerating the launch and manufacturing of bioproducts, has raised $18.4M in funding according to a recent SEC filing. The filing indicates that the total offering is for $20.6M and there were fifty-two investors in this close. Synonym was founded by Edward Shenderovich and Joshua Lachter in 2021. Parable - $16.5M seed. Parable, an intelligence platform for enterprise operations, has raised $16.5M in Seed funding led by HOF Capital. Parable was founded by Adam Schwartz, Clinton Robinson, Alex Terrien, and Steve Tam in 2024. AlleyWatch is NYC's leading source of tech and startup news, reaching the city's most active founders, investors, and tech leaders. Advertise today iVerify - $12.3M. iVerify, a threat hunting platform for mobile devices, has raised $12.3M in funding according to a recent SEC filing. The filing indicates that there were six investors in the round. Founded by Danny Rogers and Rocky Cole in 2023, iVerify has now raised a total of $28.3M in reported equity funding. General Intelligence Company of New York - $10.4M. General Intelligence Company of New York, an AI platform that allows individuals to run entire businesses autonomously, has raised $10.4M in funding according to a recent SEC filing. The filing indicates that the total offering is for $11M and there were seven investors in this close. General Intelligence Company of New York was founded by Abhishyant Khare and Andrew Pignanelli in 2025. Cob Foods - $5M seed. Cob Foods, a sorghum-based snack brand, has raised $5M in Seed funding from investors that include Novak Djokovic. Cob Foods was founded by Jessica Brondo Davidoff and Djokovic in 2022. Helex - $3.5M seed. Helex, a therapeutics company focused on treatment of chronic and rare kidney disorders, has raised $3.5M in Seed funding led by Pi Ventures. Founded by Anirudh Nishtala, Poulami Chaudhuri, and Rohini Kalvakuntla in 2021, Helex has now raised a total of $4.6M in reported equity funding.

Primient
Feb 13th, 2025
Primient and Synonym Announce Partnership to Accelerate Bioproduct Commercialization in the U.S.

Schaumburg, Ill. — Primient, a leader in plant-based, renewable ingredients, and Synonym, a biomanufacturing infrastructure developer, today announced a strategic partnership to accelerate bioproduct innovation and commercialization, furthering the U.S.’ competitive advantage in the race...

Synonym
Oct 29th, 2024
Synonym Wins DBIMP Award — Synonym

Synonym Awarded $1.89 Million by the Department of Defense for Distributed Bioindustrial Manufacturing Program

AgFunder
May 20th, 2024
Synbiobeta 2024: From Novel Hosts To ‘Tricking’ Cells To Be More Productive… Addressing The ‘Scale-Cost Paradox’ In Biomanufacturing

Since insulin produced by genetically engineered bacteria—rather than the pancreases of slaughtered animals—was first approved in 1982, the market for ‘biomanufactured’ products produced by microbial, animal, or plant cells has grown rapidly. “But in areas other than pharma—whose business models are built on high-margin, low-volume products with low sensitivity to costs—innovations have created only niche markets in enzymes, fragrances, and food and feed supplements,” concedes a recent report from Synonym and Boston Consulting Group. So what will it take to make the economics of precision fermentation stack up for a wider range of bioproducts such that they can compete with low-margin, high volume products derived from petrochemicals or industrialized animal agriculture?

vegconom GmbH
Feb 27th, 2024
Global Biomanufacturing Capacity Must Grow 20X To Reach Industry Growth Of $200 Billion By 2031, Says New Report

A recent report, co-authored by the New York-based biotech firm Synonym and Boston Consulting Group, has outlined a roadmap for the biomanufacturing industry, predicting a potential explosion to a $200 billion market in specialty sectors over the next ten years. The report Breaking the Cost Barrier on Biomanufacturing encourages the transition to biomanufacturing to address issues of sustainability and cost-efficiency in current industrial production methods. However, the report’s estimated $200 billion market value is focused on precision fermentation to produce food ingredients, chemicals, and chemical precursors. According to the authors, the figure is considered conservative and reflects only a fraction of the potential for growth within the industry

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Synonym right now.

Find jobs on Simplify and start your career today

We update Synonym's jobs every few hours, so check again soon!Browse all jobs